A Clinical Study of CD19 Targeted CAR-T for Patients With CD19+ Lymphoma and Leukemia

NCT03383952 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

B Cell Leukemia
B Cell Lymphoma

Interventions

BIOLOGICAL: ICAR19 CAR-T cells

Sponsor

Immune Cell, Inc.

Collaborators

[object Object]